Isobologram showing synergy for P505-15 plus fludarabine in a primary CLL sample (09-248). The linear lines (A, for IC50 and IC75) represent the dose combination that is expected to yield an additive drug effect while the inset lines (B, for IC50 and IC75) illustrate the synergistic effect for this drug combination).